Menu
No results found.
Weekly Share Price & Valuation Overview
Bolak Company Limited
Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, micron, and dairy flavoring products; active pharmaceutical ingredients, such as dry and soft extract powders, fluid extracts, tinctures, natural paclitaxel, docetaxel trihydrates, and Na-CMC and Ca-CMC; health subsidiary foods, including green tea extracts, soy isoflavones, and ginseng extracts; and food coloring products. It also provides gum base products; cosmetic ingredients; fragrances for use in perfumes, cosmetics, hair products, daily supplies, toilet soaps, candles, and industrial products; and other products, such as sweeteners, surfactants, whitening agents, preservatives, antioxidants, abrasives, thickening agents, thickeners, caffeine, and baking powder. Bolak Company Limited was founded in 1959 and is headquartered in Hwaseong-si, South Korea.
- Revenue growth ≥10% indicates solid top-line momentum.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Net cash balance sheet provides flexibility for downturns and investment.
- Debt/EBITDA >4 — elevated leverage vs earnings capacity.
- Market Cap Total equity value of the company (share price × shares outstanding).
- KRW 62.90B
- Enterprise Value Operating value: market cap + total debt − cash.
- KRW 59.05B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- KRW 51.19B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- KRW 4.87B
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- KRW 436.08M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- KRW 794.66
- Shares Outstanding
- 59.90M
- Float Shares
- 39.84M
- Implied Shares Outstanding
- 59.96M
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
6.49%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
85.20%
- Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
9.52%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
-1.98%
- ROA Return on assets: net income ÷ total assets.
-
-1.38%
- ROE Return on equity: net income ÷ shareholder equity.
-
-2.09%
- Revenue Growth Strong Year-over-year revenue growth.
-
16.10%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
1.35%
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 1.73
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.05
- Total Cash Cash and equivalents.
- KRW 6.00B
- Total Debt Short + long-term interest-bearing debt.
- KRW 2.15B
- Net Debt Net Cash Total debt − cash (negative = net cash).
- KRW -3.85B
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 4.93
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- KRW 4.67B
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- KRW 4.65B
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
9.12%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
9.08%
- Dividend Yield suppressed due to an anomalous value from the feed (>30%).
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.